Select Medical
SEM was delisted on the 30th of June, 2026.
180 hedge funds and large institutions have $2.02B invested in Select Medical in 2017 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 56 increasing their positions, 62 reducing their positions, and 6 closing their positions.
450% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 6
27% more call options, than puts
Call options by funds: $2.47M | Put options by funds: $1.94M
24% more capital invested
Capital invested by funds: $1.62B → $2.02B (+$394M)
16% more funds holding
Funds holding: 155 → 180 (+25)
10% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 62
1.11% less ownership
Funds ownership: 147.93% → 146.82% (-1.1%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$32.4M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$27.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$18.5M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$17.7M |
| 5 |
DM
Deerfield Management
New York
|
+$11.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$76.8M |
| 2 |
JP
Jana Partners
New York
|
-$31.3M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$13.2M |
| 4 |
BCM
Brigade Capital Management
New York
|
-$8.77M |
| 5 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$8.57M |
SEM Hedge Fund Activity: Q3 2017 in Review
180 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2017, worth a combined $2.02B — up 24% from $1.62B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new SEM positions and 6 closed out — a net gain of 27 holders — while 56 added to existing stakes and 62 trimmed.
The largest buyer was OrbiMed, adding an estimated $32.4M. The largest seller was Camber Capital Management, exiting entirely with an estimated $76.8M sold.
- 180 institutional investors held Select Medical (SEM) as of Q3 2017, up from 155 in Q2 2017.
- Funds reported $2.02B of Select Medical stock for Q3 2017, up 24% quarter-over-quarter.
- 33 funds opened new Select Medical positions in Q3 2017 and 6 closed out, a net change of +27 holders.
- The largest Select Medical buyer in Q3 2017 was OrbiMed, an estimated $32.4M added.
- The largest Select Medical seller in Q3 2017 was Camber Capital Management, an estimated $76.8M sold.
Based on aggregated 13F filings for Q3 2017.